Tocqueville Asset Management L.P. lifted its position in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 32.5% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 265,000 shares of the company's stock after purchasing an additional 65,000 shares during the period. Tocqueville Asset Management L.P. owned 0.25% of Definitive Healthcare worth $766,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Bayesian Capital Management LP purchased a new stake in shares of Definitive Healthcare during the fourth quarter worth about $41,000. Two Sigma Securities LLC purchased a new stake in shares of Definitive Healthcare during the fourth quarter worth about $56,000. Cerity Partners LLC purchased a new stake in shares of Definitive Healthcare during the first quarter worth about $56,000. ProShare Advisors LLC boosted its holdings in shares of Definitive Healthcare by 49.1% during the fourth quarter. ProShare Advisors LLC now owns 15,018 shares of the company's stock worth $62,000 after purchasing an additional 4,943 shares during the period. Finally, Meeder Asset Management Inc. bought a new position in Definitive Healthcare in the first quarter worth about $76,000. 98.67% of the stock is currently owned by hedge funds and other institutional investors.
Definitive Healthcare Stock Performance
DH stock traded up $0.2950 on Friday, hitting $4.0650. The company had a trading volume of 289,812 shares, compared to its average volume of 818,064. Definitive Healthcare Corp. has a 12-month low of $2.15 and a 12-month high of $5.68. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.39. The stock's 50-day simple moving average is $3.92 and its 200 day simple moving average is $3.56. The stock has a market cap of $581.86 million, a price-to-earnings ratio of -1.53, a P/E/G ratio of 5.31 and a beta of 1.64.
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on DH. Robert W. Baird set a $4.00 price target on shares of Definitive Healthcare in a research note on Friday, August 8th. Stifel Nicolaus raised their target price on shares of Definitive Healthcare from $5.00 to $6.00 and gave the company a "buy" rating in a research note on Friday, August 8th. BTIG Research downgraded shares of Definitive Healthcare from a "buy" rating to a "neutral" rating in a research note on Friday, May 9th. The Goldman Sachs Group raised their target price on shares of Definitive Healthcare from $3.00 to $3.40 and gave the company a "neutral" rating in a research note on Monday, May 12th. Finally, Wall Street Zen raised shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, June 21st. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Definitive Healthcare currently has a consensus rating of "Hold" and a consensus price target of $4.73.
View Our Latest Report on Definitive Healthcare
About Definitive Healthcare
(
Free Report)
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Further Reading
Before you consider Definitive Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.
While Definitive Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access